Evaluation of Pathogens in Shunt Infections Developed in Newborns Underwent Ventriculoperitoneal Shunt for Hydrocephaly
Abstract
Objectives: The ventriculoperitoneal (VP) shunt is the most commonly used treatment modality in hydrocephaly. However, VP shunt infection is a common, severe complication with high mortality and morbidity rate. The aim of the study was to evaluate clinical characteristics, shunt infections and pathogen agents in newborns underwent VP shunt procedure for hydrocephaly.
Materials and Methods: This retrospective study was conducted in Neonatal Intensive Care Unit of Harran University, Faculty of Medicine between January, 2016 and June, 2021. The study included all newborns admitted with hydrocephaly and underwent VP shunt procedure.
Results: The study included 52 cases with hydrocephaly. Of the cases shunt infection plus meningitis was develop in 28 (53.8%) while no shunt infection plus meningitis was developed in 24 (46.2%). Of the cases developed shunt infection plus meningitis, 8 were boys (28.6%) and 20 were girls (71.4%). Of the cases with growth in culture tests, Gram-positive bacteria were detected in 5 (18.0%) whereas Gram-negative enteric and nonfermenter bacteria in 22 (78.4%) and Candida parapsilosis in one (3.6%).
Conclusion: In our study, we found that the incidence of Gram-negative bacterial infection was high. We believe that treatment with Gramnegative coverage will be appropriate until culture test results available when VP shunt infection is suspected.
Keywords
Hydrocephaly, Shunt Infection, Newborn
Ethical Statement
Ethics Committee Approval: The study was approved by Ethics Committee of Harran University, Faculty of Medicine (approval date: 14.09.2017; approval no: 09-10).
Informed Consent: In all patients, informed consent was obtained for anesthesia before surgery.
Peer-reviewed: Externally peer-reviewed.
References
- 1. Fernell E, Hagberg G, Hagberg B. Infantile hydrocephalus epidemiology: an indicator of enhanced survival. Arch Dis Child Fetal Neonatal Ed. 1994;70:F123-F128.
- 2. Telhan L, Çavuşoğlu F, Müslüman M, et al. Ventriküloperitoneal şant enfeksiyonu gelişmiş çocukların etiyolojik ve prognostik açılardan değerlendirilmesi. Çocuk Enf Derg. 2010;3:100-103.
- 3. Glees P, Voth DJNr. Clinical and ultrastructural observations of maturing human frontal cortex. Part I (Biopsy material of hydrocephalic infants). Neurosurg Rev. 1988;11:273-278.
- 4. Choux M, Genitori L, Lang D, et al. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg. 1992;77:875-880.
- 5. Zemack G, Romner B. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients. J Neurosurg. 2000;92:941-948.
- 6. Vanaclocha V, Saiz-Sapena N, Leiva J. Shunt malfunction in relation toshunt infection. Acta Neurochir (Wien). 1996;138:829-834.
- 7. Piatt Jr JH, Carlson CV. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg. 1993;19:233-242.
- 8. Ammirati M, Raimondi AJ. Cerebrospinal fluid shunt infections in children. Childs Nerv Syst. 1987;3:106-109.
- 9. Davis SE, Levy ML, McComb JG, et al. Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg. 1999;30:253-257.
- 10. Kanik A, Sirin S, Kose E, et al. Clinical and economic results of ventriculoperitoneal shunt infections in children. Turk Neurosurg. 2015;25:58-62.